Alzheimers therapeutics (MIGENIX/Pfizer)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAlzheimers therapeutics (MIGENIX/Pfizer)
Drug Alias NameAlzheimers therapeutics (Micrologix/Pfizer)Alzheimers therapeutics (MitoKor/Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCNS modulators
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitokor
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlobal Gaming Technologies CorpMitokorPfizer Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A